Series A

Fueled by strong investor demand and a lead order from Purpose Global Resource Fund, Lithium Africa will acquire a key South African lithium asset.

With book value soaring, Stack Capital offers a rare public window into the massive valuations of private titans like SpaceX and the AI infrastructure boom.

With FDA Breakthrough status for its MASH drug, a new CEO, and a fortified balance sheet, Altimmune is poised to take on serious liver disease and addiction.

A new strategic partnership between AlbaCore and MUFG aims to unlock billions for UK and European infrastructure, offering investors access to stable returns.

Phoenix innovator GACW proves its steel Air Suspension Wheel in brutal -40°F mining tests, paving the way for a safer, non-pneumatic 2026 commercial release.

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

SaaS growth expert Eric Shoemaker takes the helm at Keebo, aiming to scale its AI-powered platform amid soaring enterprise demand for cloud cost control.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

Novos Power and WearableDose win FedTech's Crucible competition, highlighting critical innovations in power grid stability and real-time radiation monitoring.

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

With 10 million users acquired organically, Presentations.AI is leading a shift from static slides to dynamic, AI-powered 'decision infrastructure'.

Facing slow auto OEM cycles, Arbe Robotics names a new CEO and targets defense, robotaxis, and China to accelerate revenue from its high-res radar tech.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

With its CFO at a key forum, Syntiant leverages 100M+ chip deployments to prove the value of on-device intelligence in a booming multi-billion dollar market.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

As AI agents and non-human identities multiply, Hush Security's new platform aims to replace risky static secrets with unified, identity-based access.

A new AI platform, Alti, claims to boost productivity and retention by creating a 'digital twin' to optimize employee well-being. But can it deliver?

A new self-serve platform offers on-demand NVIDIA and AMD systems locally, providing an alternative to cloud costs and lock-in for AI and VFX industries.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.